Article

3 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    9 3 0 0


Biomedicine and pharmacotherapy
Volume 64, n° 4
pages 240-248 (avril 2010)
Doi : 10.1016/j.biopha.2009.06.019
Received : 17 November 2008 ;  accepted : 7 June 2009
Original articles

GMDP augments antitumor action of the CP/TNF⍺ combination in vivo
 

Elena E. Petrova a, , Maria A. Simonova a, Ravilya L. Komaleva a, Marina V. Britsina b, Tatiana M. Andronova a, Vladimir A. Nesmeyanov a, Tatiana I. Valyakina a
a Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10, Mikhlukho-Macklaya street, Moscow 117997, Russian Federation 
b Mechnikov Institute of Vaccines and Serums, Russian Academy of Medical Sciences, Moscow, Russian Federation 

Corresponding author.
Abstract

We have shown that glucosaminyl muramyl dipeptide (GMDP) has been augmented the antitumor action of chemotherapy drug cisplatin and tumor necrosis factor-⍺ (TNF⍺) on the Ehrlich ascites carcinoma and melanoma B-16 mouse tumor models. The doses of cisplatin, TNF⍺ and GMDP and also the conditions of the drugs combination injection provided 100% survival of mice with Ehrlich ascites carcinoma were found. Furthermore, it was shown first that GMDP has been decreased toxicity of the cisplatin/TNF⍺ combination and normalized the changes in the experimental mice hematological parameters which were produced by the CP/TNF⍺ combination.

The full text of this article is available in PDF format.

Keywords : Glucosaminyl muramyl dipeptide, Chemotherapy, Tumor necrosis factor




© 2009  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline